Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Petrie

Showing results (41-50 of 675) with videos related to

Pageof 68
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 2, 1998
Bupropion and desipramine increase dopamine transporter mRNA expression in the ventral tegmental area/substantia nigra of rat brainE C Petrie, R C Veith, P Szot
European Heart Journal. Cardiovascular Pharmacotherapy|February 17, 2024
Reply: subcutaneous furosemide patch: heart failure decongestion 'from the comfort of your home'Joanna Osmanska, Mark C Petrie, Ross T Campbell
British Medical Bulletin|April 1, 1994
Drug treatment: present and futureD Lyons, J C Petrie, J L Reid
American Heart Journal|March 1, 1977
Atenolol in hypertensionJ C Petrie, T A Jeffers, J Webster
Journal of Hypertension|January 1, 1989
Linear cardiac output in borderline and sustained hypertensionJ M Rawles, J Webster, J C Petrie
European Journal of Heart Failure|April 1, 2020
Implantable cardioverter-defibrillators and survival - the fine line between efficacy concerns and ageismNathaniel M Hawkins, Joanna Osmanska, Mark C Petrie
British Medical Journal (Clinical Research Ed.)|June 1, 1985
Initial dose of enalapril in hypertensionJ Webster, D M Newnham, J C Petrie
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
DANAMI-2: the end of the thrombolytic eraM C Petrie, R L Anthonio, F Zijlstra
BMJ (Clinical Research Ed.)|August 12, 2010
Congestive heart failure. Advances in managementJonathan R Dalzell, Mark C Petrie, Roy S Gardner
European Journal of Heart Failure|January 13, 2018
Who needs an implantable cardioverter-defibrillator? Controversies and opportunities after DANISHMark C Petrie, Derek T Connelly, Roy S Gardner
Pageof 68

Showing results (41-50 of 675) with videos related to

Sort By:
Pageof 68
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 2, 1998
Bupropion and desipramine increase dopamine transporter mRNA expression in the ventral tegmental area/substantia nigra of rat brainE C Petrie, R C Veith, P Szot
European Heart Journal. Cardiovascular Pharmacotherapy|February 17, 2024
Reply: subcutaneous furosemide patch: heart failure decongestion 'from the comfort of your home'Joanna Osmanska, Mark C Petrie, Ross T Campbell
British Medical Bulletin|April 1, 1994
Drug treatment: present and futureD Lyons, J C Petrie, J L Reid
American Heart Journal|March 1, 1977
Atenolol in hypertensionJ C Petrie, T A Jeffers, J Webster
Journal of Hypertension|January 1, 1989
Linear cardiac output in borderline and sustained hypertensionJ M Rawles, J Webster, J C Petrie
European Journal of Heart Failure|April 1, 2020
Implantable cardioverter-defibrillators and survival - the fine line between efficacy concerns and ageismNathaniel M Hawkins, Joanna Osmanska, Mark C Petrie
British Medical Journal (Clinical Research Ed.)|June 1, 1985
Initial dose of enalapril in hypertensionJ Webster, D M Newnham, J C Petrie
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
DANAMI-2: the end of the thrombolytic eraM C Petrie, R L Anthonio, F Zijlstra
BMJ (Clinical Research Ed.)|August 12, 2010
Congestive heart failure. Advances in managementJonathan R Dalzell, Mark C Petrie, Roy S Gardner
European Journal of Heart Failure|January 13, 2018
Who needs an implantable cardioverter-defibrillator? Controversies and opportunities after DANISHMark C Petrie, Derek T Connelly, Roy S Gardner
Pageof 68